Greco Theresa has filed 14 insider transactions across 1 company since November 2023.
Most recent transaction: a tax payment of 879 shares of OptimizeRx Corp ($OPRX) on May 15, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 15, 2026 | OptimizeRx Corp | $OPRX | Greco Theresa | Chief Commercial Officer | F | Common Stock | 879 | $5.21 | 71,075.0000 | 20,333,839 | 1.22% | 0.00% |
| May 15, 2026 | OptimizeRx Corp | $OPRX | Greco Theresa | Chief Commercial Officer | F | Common Stock | 914 | $5.21 | 71,954.0000 | 20,333,839 | 1.25% | 0.00% |
| Dec. 23, 2025 | OptimizeRx Corp | $OPRX | Greco Theresa | Chief Commercial Officer | F | Common Stock | 1420 | $12.74 | 72,868.0000 | 20,333,839 | 1.91% | 0.01% |
| Nov. 1, 2025 | OptimizeRx Corp | $OPRX | Greco Theresa | Chief Commercial Officer | F | Common Stock | 1693 | $20.49 | 74,288.0000 | 20,333,839 | 2.23% | 0.01% |
| Aug. 21, 2025 | OptimizeRx Corp | $OPRX | Greco Theresa | Chief Commercial Officer | A | Stock Option | 35156 | $0.00 | 35,156.0000 | 20,297,388 | 9999.99% | 0.17% |
| Aug. 21, 2025 | OptimizeRx Corp | $OPRX | Greco Theresa | Chief Commercial Officer | A | Common Stock | 15625 | $0.00 | 75,981.0000 | 20,297,388 | 25.89% | 0.08% |
| May 15, 2025 | OptimizeRx Corp | $OPRX | Greco Theresa | Chief Commercial Officer | A | Common Stock | 2441 | $0.00 | 53,314.0000 | 20,234,186 | 4.80% | 0.01% |
| May 15, 2025 | OptimizeRx Corp | $OPRX | Greco Theresa | Chief Commercial Officer | A | Common Stock | 7042 | $0.00 | 60,356.0000 | 20,234,186 | 13.21% | 0.03% |
| May 15, 2025 | OptimizeRx Corp | $OPRX | Greco Theresa | Chief Commercial Officer | A | Stock Option | 12133 | $0.00 | 12,133.0000 | 20,234,186 | 9999.99% | 0.06% |
| Dec. 23, 2024 | OptimizeRx Corp | $OPRX | Greco Theresa | Chief Commercial Officer | A | Common Stock | 15528 | $0.00 | 50,873.0000 | 20,069,432 | 43.93% | 0.08% |
| Dec. 23, 2024 | OptimizeRx Corp | $OPRX | Greco Theresa | Chief Commercial Officer | A | Stock Option | 29153 | $0.00 | 29,153.0000 | 20,069,432 | 9999.99% | 0.15% |
| Nov. 1, 2024 | OptimizeRx Corp | $OPRX | Greco Theresa | Chief Commercial Officer | F | Common Stock | 1693 | $5.15 | 35,345.0000 | 20,069,432 | 4.57% | 0.01% |
| Nov. 1, 2023 | OptimizeRx Corp | $OPRX | Greco Theresa | Chief Commercial Officer | A | Stock Option | 35758 | $0.00 | 35,758.0000 | 0 | 9999.99% | 0.00% |
| Nov. 1, 2023 | OptimizeRx Corp | $OPRX | Greco Theresa | Chief Commercial Officer | A | Common Stock | 18519 | $0.00 | 37,038.0000 | 0 | 100.00% | 0.00% |